Insider filing · NTRA
Rowan E Chapman
Director
profile →
Natera, Inc.
NTRA · Healthcare · 229 filings in 24 months
ticker →
Rowan E Chapman sold $459K of Natera (NTRA)
Executed Aug 28 2025, disclosed Sep 2 2025, 5 days later.
Value, as filed
$459K
2,750 sh × $166.99
Executed
Aug 28 2025
the trade date, as filed
Disclosed
Sep 2 2025
5 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RCRowan E Chapman (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Natera, Inc. (NTRA). The largest single filing was $972K of NTRA (4,000 sh × $243.08, as filed), executed Dec 5 2025.
The name
NTRAHealthcare · Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Rowan E Chapman in NTRA
NTRASALE
Natera, Inc.
$643K2,964 sh × $216.78
Exec Jun 16
Filed Jun 17 · 5:30 PM ET NTRASALE Natera, Inc. $972K
4,000 sh × $243.08
Exec Dec 5 2025
Filed Dec 9 2025 · 5:30 PM ET NTRASALE Natera, Inc. $301K
1,767 sh × $170.24
Exec Dec 10 2024
Filed Dec 11 2024 · 5:30 PM ET